The information on this website is intended for general information only. Gravitate Health Consortium makes no warranty or representation of any kind as to the accuracy or availability of such information, and shall not be responsible in any way for any use of or reliance on such information by any legal or natural person. Neither Gravitate Health Consortium nor any party involved in creating, producing or delivering this website shall be liable for any damages, including without limitation, direct, incidental, consequential, indirect or punitive damages, arising out of access to, use of or inability to use this website, or any errors or omissions in the content thereof. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.
Gravitate Health Consortium, makes no representation or warranty that the use of this website, or materials downloaded from it, will not cause computer virus infection or other damage to property. You are advised to ensure that you have adequate measures to prevent any such problems.
Embedded content from other websites
Articles on this website may include embedded content (e.g. videos, charts, etc.). Embedded content from other websites behaves in the exact same way as if the visitor had visited the other website.
Gravitate Health, Consortium is not responsible for any website that may be accessed from links on this website, and makes no representation or warranty as to their availability, or the suitability or accuracy of their content. If you choose to visit these websites, you do so at your own risk.
Gravitate Health is an EU funded project which has received funding from the Innovative Medicines Initiative (IMI) with support from Horizon 2020 programme, the European Federation of Pharmaceutical Industries and Associations (EFPIA) and IMI2 Associated Partner Datapharm Ltd. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. Read more at: www.imi.europa.eu